Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 125 (RPL21P125) is a processed pseudogene; it does not encode a functional protein and is not an active component of the ribosome or involved in protein synthesis. Pseudogenes are typically non-functional remnants of genes that have lost their ability to code for a protein, and they are common for ribosomal protein genes due to their evolutionary history. As such, RPL21P125 is not a therapeutic target, does not have a known biological function, disease association, or pharmacological relevance [1][4]. The functional gene in this family is ribosomal protein L21 (RPL21), which encodes a protein component of the 60S large ribosomal subunit [3][4]. Multiple pseudogenes for ribosomal proteins exist, including many with similar names, but these are generally non-functional [3][4]. There is something "wrong" with this target for drug discovery purposes: as a pseudogene, RPL21P125 is not a therapeutically relevant molecule and does not serve as a receptor, enzyme, transporter, or any other typical molecular drug target [1][4]. Direct genetic information for pseudogenes such as RPL21P125 is limited to gene product catalogs and databases, with no evidence for biological function or disease association [1]. The functional RPL21 gene codes for a structurally relevant ribosomal protein [3][4], but pseudogenes like RPL21P125 are non-coding, non-therapeutic, and not of practical clinical or research utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 125 (RPL21P125).